The notices it replaced
- Reissues: PAR-18-629
Replaced by PAR-21-290.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,565,344 in first-year total cost, median $623,422.
Most frequent study sections
- Clinical Translational Imaging Science Study Section[CTIS]4
- Special Emphasis Panel[ZRG1 CTIS-C (07)]1
- Special Emphasis Panel[ZRG1 SBIB-Q (03)]1
Most frequent institutions
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2
- UNIVERSITY OF WASHINGTON2
- QUEEN'S MEDICAL CENTER1
- UNIVERSITY OF SOUTHERN CALIFORNIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Biomarkers of Response to Immuno-chemotherapy & oliGometastatic Hypofractionated radioTherapy (BRIGHT) for Lung Cancer: Synergy of PET/CT Imaging and Peripheral Blood Assays1R01CA258997-01A1 | BOWEN, STEPHEN R.ZENG, JING | UNIVERSITY OF WASHINGTON, WA | $622,286 | CTIS |
| 2021 | Integrated radiomic and liquid biopsy monitoring in SWOG S1802: A phase 3 therapeutic trial for metastatic prostate cancer1R01CA257610-01 | DUDDALWAR, VINAYGOLDKORN, AMIRTRICHE, TIMOTHY J. | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $706,071 | ZRG1 |
| 2021 | Strategy for combining circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) measures of tumor burden for prediction of response and outcome in neoadjuvant-treated early breast cancer1R01CA255442-01 | LI, WENMAGBANUA, MARK JESUSVAN'T VEER, LAURA J | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $670,223 | CTIS |
| 2021 | Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy1R01CA256969-01 | COLLISSON, ERICGOENKA, AJIT HARISHKUMARWANG, ZHEN JANE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $624,558 | CTIS |
| 2021 | Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma1R01CA262460-01 | KWEE, SANDI ALEXANDER | QUEEN'S MEDICAL CENTER, HI | $520,008 | CTIS |
| 2021 | Role of ctDNA change as a response measure in the EA1183 patient population and how ctDNA changes correlate with metabolic response by serial FDG PET/CT1R01CA251803-01A1 | SPECHT, JENNIFER MARIE | UNIVERSITY OF WASHINGTON, WA | $422,198 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.